If you've gotten the message — voicemail from an Optum care advocate, a portal note, a request for a "peer-to-peer" — the panic question is usually the same one from the r/therapists thread this week: do I have to engage with this? Here's the honest read for a NY/NJ/CT private-practice clinician.
What an Optum "clinical review" actually is
Strip the friendly language off it. A clinical review is utilization management. On most UnitedHealthcare commercial plans, outpatient individual therapy (CPT 90832–90837) runs without prior authorization for an initial block of sessions; past that block, a concurrent review or continued-stay review can trigger, where Optum asks you to demonstrate that ongoing care is still medically necessary.
It is not a disciplinary action. It is not an audit of you as a clinician. It is the payer deciding whether to keep paying, using its own criteria, on a clock it controls. That distinction matters, because the dread it produces — the sense that you've been summoned — is doing exactly what the process is structured to do: get you to either over-explain on the phone or give up and stop billing.
You are allowed to slow it down. You can ask for the request in writing, ask which criteria set is being applied, and schedule the call for when you have the chart open. None of that is non-compliance. It's just refusing to be reviewed off the top of your head.
So do you have to engage?
Mostly, if you want to keep getting paid for the sessions in question, yes — but on terms you can shape.
Engaging protects the claim. Declining the review entirely usually means the continued-stay request gets denied for lack of information, and you're then appealing from behind. So "ignore it" is rarely the move. But "engage" doesn't mean "submit to a same-day phone interrogation with a reviewer reading from a script."
Two things are worth knowing before you pick up. First, the people on the other end often aren't your clinical peers in any meaningful sense. In the 2025 AMA prior-authorization survey (released May 13, 2026), only 16% of physicians who do peer-to-peer reviews said the health-plan reviewer often or always had the appropriate qualifications (AMA, 2026). You are frequently explaining medical necessity to someone less specialized in your modality than you are. Knowing that changes how you prepare — you lead with the documented record, not a clinical debate.
Second, this is a volume machine, not a careful one. The same AMA survey found prior authorization eats an average of 13 hours of physician and staff time per week, with physicians completing about 40 of them weekly, and 94% saying it contributes to burnout (AMA, 2026). The reviewer is moving fast. Clean, ready documentation is what gets you through the gate without a fight.
The Wit ruling changed what they're allowed to use against you
For years, the open secret in behavioral health was that UnitedHealth's review arm wasn't measuring care against the field's standards — it was measuring care against its own narrower, acute-stabilization-focused internal guidelines. Wit v. United Behavioral Health is the case that put that on the record. In August 2025, the district court reaffirmed that UBH breached its fiduciary duties of loyalty and care by designing coverage guidelines that prioritized its financial interests over members' between 2011 and 2017 (The Kennedy Forum, 2026).
Then, on February 3, 2026, the court extended its injunction for five additional years, through February 3, 2031, barring UBH from reverting to those guidelines and requiring it to use coverage criteria that "accurately reflect" generally accepted standards of care and applicable state law (The Kennedy Forum, 2026).
In practice: when Optum runs a clinical review, the standard it's supposed to apply is the field's standard of care — not an in-house rule built to end episodes early. If a reviewer is pushing "you've stabilized, so we can step you down," and your clinical picture says otherwise, the burden is on their criteria to match accepted practice. That's the difference between a review you walk into apologizing and one you walk into citing the chart.
What documentation survives a clinical review
A concurrent review is decided on what's written, not what was said in the room. Reviewers want to see active medical necessity for continued care, and the records that hold up share a few features.
- Functional impairment, named concretely. "Client reports feeling sad" doesn't survive review. "Client missed three workdays this week, unable to leave bed" does. Reviewers read for impairment that justifies the level of care, so the impairment has to be on the page.
- Standardized measures, tracked over time. A PHQ-9 of 18 at intake and a GAD-7 of 16, re-administered every four to six weeks, give a reviewer an objective severity and an objective trend. When scores stay clinical, that's continued medical necessity they can't easily argue with.
- A medical-necessity line per note. Close each note with one sentence linking this week's symptoms, this week's impairment, the intervention you delivered, and why care continues. That's the exact thread a reviewer follows.
- Treatment plan and notes that actually match. When the plan says one thing and the notes drift somewhere else, the claim breaks at the seam. Payers look for a clean line from diagnosis to goals to interventions to outcomes.
This is also where "stabilization is the goal" gets clinicians in trouble: a flat or maintained score can read as "no progress, no necessity" to a fast reviewer. So you document the clinical reason maintenance is the medically necessary work — relapse risk, decompensation history, the function the sessions are holding in place. (More on building the record before the denial in what to document to win a parity denial.)
The parity backstop you can name
There's a second layer of leverage, and it's worth knowing it exists even if you never have to invoke it. Under the 2024 federal mental-health-parity (MHPAEA) final rule, the provisions barring discriminatory factors and requiring outcomes data took effect for plan years beginning on or after January 1, 2026 (U.S. Department of Labor fact sheet, 2024). The core requirement: nonquantitative treatment limitations — utilization review, concurrent review, the very thing happening on that phone call — must be applied no more stringently to mental health than to comparable medical/surgical care, both as written and in operation.
Regulators are watching this specific lever. In the federal tri-agency MHPAEA Report to Congress released January 17, 2025, concurrent care review was named one of six priority enforcement areas, and utilization-management limits made up the largest share of CMS noncompliance findings (2024 MHPAEA Report to Congress, CMS, 2025). And after the final rule landed, California's insurance regulators reviewed fully insured plans and found most or all of them out of compliance with the NQTL requirements in at least one respect (Venable LLP, 2024).
You're not going to litigate parity on a Tuesday-afternoon review call. But the framing — the law requires your review of this behavioral-health claim to be no more stringent than your review of a comparable medical claim — is a legitimate thing to put in an appeal, and reviewers know it's there.
What to actually do when the call comes
1. Don't take it cold. Ask for the request in writing and schedule the review with the chart in front of you. Preparation is the whole game. 2. Ask which criteria they're applying. Post-Wit, UBH's criteria are supposed to reflect generally accepted standards of care. Naming the criteria set on the record matters if this becomes an appeal. 3. Lead with the documented record, not a clinical argument — functional impairment, measures, the medical-necessity thread. You're confirming what's already written, not persuading from scratch. 4. If denied, request the peer-to-peer promptly (there are time limits), then appeal in writing. You generally have about 180 days for an internal appeal on UHC plans; calendar it the day the denial arrives. 5. Keep the parity language in your back pocket for the written appeal: NQTLs applied no more stringently than med/surg, per the rule effective January 2026.
The structural problem underneath all of this is that the documentation a review demands is the same documentation your EHR makes miserable to produce — which is why so much of clinicians' real clinical record lives in a separate Word doc instead of somewhere a review can actually use. VibeCheck is built by a clinician who has sat through these reviews, around the record you'd actually want when Optum calls: functional-impairment language, tracked measures, and a medical-necessity thread that's already written, not reconstructed at 4 p.m. on a Tuesday. The review still comes. You just stop walking into it empty-handed.
FAQ
Do I legally have to take an Optum clinical-review call?
There's no law forcing you onto a same-day phone review. But for continued-stay or concurrent reviews on plans that require them, declining to provide the requested clinical information typically results in a denial of ongoing authorization — so engaging (on your schedule, with the chart ready) protects the claim. Ignoring it usually means appealing from behind.
What is the difference between a clinical review and a peer-to-peer?
A clinical review (concurrent/continued-stay review) is the broader utilization-management check on whether ongoing care is medically necessary. A peer-to-peer is a specific step — usually after an adverse decision — where your treating clinician speaks directly with the plan's reviewer. Request the peer-to-peer promptly, because there are time limits before it converts to a formal appeal.
How does the 2026 Wit ruling affect my reviews?
On February 3, 2026, a federal court extended its injunction through February 3, 2031, requiring United Behavioral Health to use coverage criteria reflecting generally accepted standards of care, not its own narrower internal guidelines (The Kennedy Forum, 2026). It doesn't end reviews, but it constrains the criteria a reviewer is supposed to apply — useful leverage in an appeal.
What single thing makes a clinical review go smoothly?
Documentation that's already review-ready: concrete functional-impairment language, standardized measures (like PHQ-9/GAD-7) tracked over time, and a one-line medical-necessity statement in each note tying symptoms, impairment, intervention, and rationale for continued care. Reviews are decided on what's written, not what was discussed.
---